Correspondence on 'Interleukin 6 receptor inhibition in primary Sjogren syndrome: a multicentre double-blind randomised placebo-controlled trial'

被引：4
|
作者：
Wang, Bin [1 ]
Chen, Shiju [1 ]
Xuan, Jingxiu [1 ]
Li, Yan [1 ]
Zheng, Qing [1 ]
Zhang, Xinwei [1 ]
Liu, Yuan [1 ]
Shi, Guixiu [1 ,2 ]
机构：
[1] Xiamen Univ, Affiliated Hosp 1, Dept Rheumatol & Clin Immunol, Xiamen, Peoples R China
[2] Xiamen Key Lab Rheumatol & Clin Immunol, Dept Sci & Technol, Xiamen, Peoples R China
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2023年 / 82卷 / 03期
基金：
中国博士后科学基金;
关键词：
D O I：
10.1136/annrheumdis-2020-219666
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Interleukin 6 receptor inhibition in primary Sjogren syndrome: a multicentre double-blind randomised placebo-controlled trial
    Felten, Renaud
    Devauchelle-Pensec, Valerie
    Seror, Raphaele
    Duffau, Pierre
    Saadoun, David
    Hachulla, Eric
    Yves, Hatron Pierre
    Salliot, Carine
    Perdriger, Aleth
    Morel, Jacques
    Mekinian, Arsene
    Vittecoq, Olivier
    Berthelot, Jean-Marie
    Dernis, Emanuelle
    Le Guern, Veronique
    Dieude, Philippe
    Larroche, Claire
    Richez, Christophe
    Martin, Thierry
    Zarnitsky, Charles
    Blaison, Gilles
    Kieffer, Pierre
    Maurier, Francois
    Dellal, Azeddine
    Rist, Stephanie
    Andres, Emmanuel
    Contis, Anne
    Chatelus, Emmanuel
    Sordet, Christelle
    Sibilia, Jean
    Arnold, Cecile
    Tawk, Mira Y.
    Aberkane, Ouafaa
    Holterbach, Lise
    Cacoub, Patrice
    Saraux, Alain
    Mariette, Xavier
    Meyer, Nicolas
    Gottenberg, Jacques-Eric
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 (03) : 329 - 338
  • [2] Correspondence on 'Interleukin 6 receptor inhibition in primary Sjogren syndrome: a multicentre double-blind randomised controlled trial'
    de Wolff, Liseth
    Arends, Suzanne
    Verstappen, Gwenny M.
    Vissink, Arjan
    Kroese, Frans G. M.
    Bootsma, Hendrika
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 (06) : E148 - E148
  • [3] Response to: 'Correspondence on 'Interleukin 6 receptor inhibition in primary Sjogren syndrome: a multicentre double-blind randomised placebo-controlled trial'' by Wang et al
    Felten, Renaud
    Gottenberg, Jacques-Eric
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 (03)
  • [4] Response to: 'Correspondence on 'Interleukin 6 receptor inhibition in primary Sjogren syndrome: a multicentre double-blind randomised placebo-controlled trial'' by de Wolff et al
    Felten, Renaud
    Gottenberg, Jacques-Eric
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 (06) : E149 - E149
  • [5] Safety and efficacy of thalidomide in patients with POEMS syndrome: a multicentre, randomised, double-blind, placebo-controlled trial
    Misawa, Sonoko
    Sato, Yasunori
    Katayama, Kanako
    Nagashima, Kengo
    Aoyagi, Reiko
    Sekiguchi, Yukari
    Sobue, Gen
    Koike, Haruki
    Yabe, Ichiro
    Sasaki, Hidenao
    Watanabe, Osamu
    Takashima, Hiroshi
    Nishizawa, Masatoyo
    Kawachi, Izumi
    Kusunoki, Susumu
    Mitsui, Yoshiyuki
    Kikuchi, Seiji
    Nakashima, Ichiro
    Ikeda, Shu-ichi
    Kohara, Nobuo
    Kanda, Takashi
    Kira, Jun-ichi
    Hanaoka, Hideki
    Kuwabara, Satoshi
    LANCET NEUROLOGY, 2016, 15 (11): : 1129 - 1137
  • [6] Mitoxantrone in progressive multiple sclerosis:: a placebo-controlled, double-blind, randomised, multicentre trial
    Hartung, HP
    Gonsette, R
    König, N
    Kwiecinski, H
    Guseo, A
    Morrissey, SP
    Krapf, H
    Zwingers, T
    LANCET, 2002, 360 (9350): : 2018 - 2025
  • [7] Prophylactic ibuprofen in premature infants:: a multicentre, randomised, double-blind, placebo-controlled trial
    Van Overmeire, B
    Allegaert, K
    Casaer, A
    Debauche, C
    Decaluwé, W
    Jespers, A
    Weyler, J
    Harrewijn, I
    Langhendries, JP
    LANCET, 2004, 364 (9449): : 1945 - 1949
  • [8] Effect of Interleukin-6 Receptor Inhibition with Tocilizumab in Patients With Rheumatoid Arthritis (OPTION Study): A Double-Blind, Placebo-Controlled, Randomised Trial
    Dejaco, C.
    Duftner, C.
    JOURNAL FUR MINERALSTOFFWECHSEL, 2008, 15 (02): : 101 - +
  • [9] Effect of interleukin-6 receptor inhibition with tocilizumab in patients with rheumatoid arthritis (OPTION study): a double-blind, placebo-controlled, randomised trial
    Smolen, Josef S.
    Beaulieu, Andre
    Rubbert-Roth, Andrea
    Ramos-Remus, Cesar
    Rovensky, Josef
    Alecock, Emma
    Woodworth, Thasia
    Alten, Rieke
    LANCET, 2008, 371 (9617): : 987 - 997
  • [10] Effectiveness of Rituximab Treatment in Primary Sjogren's Syndrome A Randomized, Double-Blind, Placebo-Controlled Trial
    Meijer, J. M.
    Meiners, P. M.
    Vissink, A.
    Spijkervet, F. K. L.
    Abdulahad, W.
    Kamminga, N.
    Brouwer, E.
    Kallenberg, C. G. M.
    Bootsma, H.
    ARTHRITIS AND RHEUMATISM, 2010, 62 (04): : 960 - 968
12345